1-3 of 3
Christopher DeBoever
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia

Clinical Trials & Observations
Bing Cui, Emanuela M. Ghia, Liguang Chen, Laura Z. Rassenti, Christopher DeBoever, George F. Widhopf, II, Jian Yu, Donna S. Neuberg, William G. Wierda, Kanti R. Rai, Neil E. Kay, Jennifer R. Brown, Jeffrey A. Jones, John G. Gribben, Kelly A. Frazer, Thomas J. Kipps
Journal: Blood
Blood (2016) 128 (25): 2931–2940.
https://doi.org/10.1182/blood-2016-04-712562
Published: 2016
Includes: Supplemental data
Journal Articles

ROR1 Negative Chronic Lymphocytic Leukemia (CLL) Have a Distinctive Gene Expression Signature and May Represent an Indolent-Disease Subtype

Emanuela M. Ghia, PhD, Laura Z. Rassenti, PhD, Liguang Chen, MD PhD, Bing Cui, PhD, Christopher Deboever, BS, Kelly A. Frazer, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 2932.
https://doi.org/10.1182/blood.V126.23.2932.2932
Published: 2015
Journal Articles

Genomic Analysis of Serial Chronic Lymphocytic Leukemia Samples Suggests That Epigenetic Changes, Rather Than Clonal Evolution, May Drive the Progression of This Leukemia

Emanuela M. Ghia, PhD, Erin Smith, PhD, Christopher DeBoever, Laura Z. Rassenti, Ph.D., Sophie Rozenzhak, Peter Shepard, PhD, Hakan Alakus, M.D., Olivier Harismendy, PhD, Christian L Barrett, Ph.D., Kelly A Frazer, Ph.D., Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4563.
https://doi.org/10.1182/blood.V120.21.4563.4563
Published: 2012